Frazier Life Sciences X, L.P. is of HilleVax, Inc.. Currently has a direct ownership of 8.54 Million shares of HLVX, which is worth approximately $15.9 Million. The most recent transaction as insider was on Apr 04, 2024, when has been sold 8,850 shares (Common Stock) at a price of $14.5 per share, resulting in proceeds of $128,325. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.54M
0% 3M change
0.1% 12M change
Total Value Held $15.9 Million

Frazier Life Sciences X, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 04 2024
BUY
Open market or private purchase
$128,325 $14.5 p/Share
8,850 Added 0.1%
8,544,187 Common Stock
May 03 2022
BUY
Open market or private purchase
$30,000,002 $17.0 p/Share
1,764,706 Added 17.13%
8,535,337 Common Stock
May 03 2022
BUY
Conversion of derivative security
$37,212,783 $13.6 p/Share
2,736,234 Added 28.78%
6,770,631 Common Stock

Also insider at

MBX
MBX Biosciences, Inc.
FLS

Frazier Life Sciences X, L.P.

Seattle, WA

Track Institutional and Insider Activities on HLVX

Follow HilleVax, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HLVX shares.

Notify only if

Insider Trading

Get notified when an Hille Vax, Inc. insider buys or sells HLVX shares.

Notify only if

News

Receive news related to HilleVax, Inc.

Track Activities on HLVX